Amebiasis and Pathogenic Free-Living Amebae

## Amebiasis and Pathogenic Free-Living Amebae ## 1. Immunity in Amebiasis Infection with **_Entamoeba histolytica_** triggers both **humoral and cellular immune responses**. Systemic antibodies can be detected as early as one week following an invasive infection. **IgG** is the predominant immunoglobulin produced, while **IgA** plays a critical role in resisting the **Gal/GalNAc lectin** of the parasite. In endemic areas, prior infection confers some protection, which is evidenced by a low frequency of recurrence of **invasive colitis** and **liver abscess**. Interestingly, the severity of amebiasis does not appear to be significantly altered by **HIV** status. ## 2. Treatment of Amebiasis ### A. Drug Categories Treatment for amebiasis involves different categories of drugs, each targeting specific forms or locations of the parasite: * **Luminal Amebicides**: These drugs are effective only in the intestinal lumen, targeting both cysts and trophozoites. Examples include **Diloxanide furoate**, **Iodoquinol**, **Paromomycin**, and **Tetracycline**. * **Tissue Amebicides**: These are used for systemic infections, such as **liver abscess**. Drugs in this category include **Emetine** and **Chloroquine**. * **Mixed Amebicides**: These agents are effective for both intestinal and systemic infections. **Metronidazole** is the standard treatment, often alongside **Tinidazole**, **Rinidazole**, and **Omidazole**. It is important to note that **Metronidazole** should be combined with a luminal agent (e.g., **paromomycin**) to ensure complete eradication of the parasite from the gut lumen. ### B. Prophylaxis Prevention of amebiasis primarily focuses on interrupting the fecal-oral route of transmission. This involves strict adherence to sanitation practices and personal hygiene. Additionally, the detection and exclusion of carriers from food handling roles are crucial prophylactic measures. ## 3. Non-Pathogenic Intestinal Amebae Several amebae can inhabit the human intestine without causing disease. These **non-pathogenic intestinal amebae** are important to distinguish from pathogenic species during diagnosis: * **_Entamoeba coli_**: This is a common commensal organism. Its trophozoites are characterized by an **eccentric karyosome** and **coarse chromatin**. Mature cysts typically have **eight nuclei** and distinctive **splinter-like chromatoid bodies**. * **_Entamoeba hartmanni_**: Similar in appearance to _E. histolytica_ but significantly smaller, with trophozoites measuring 4-12 µm. It is considered **non-pathogenic**. * **_Entamoeba gingivalis_**: Found in gingival tissues, this ameba exists only in the **trophozoite stage**. Transmission occurs via **direct oral contact**. * **_Endolimax nana_**: A small commensal ameba, typically less than 10 µm. Its cysts are characteristically **oval and quadrinucleate**. * **_Iodamoeba butschlii_**: This ameba is distinguished by a large, prominent **iodine-staining glycogen mass (iodophilic body)** within its cyst. ## 4. Pathogenic Free-Living Amebae Unlike _Entamoeba histolytica_, these amebae are typically found in the environment and can cause severe, often fatal, infections in humans. ### A. _Naegleria fowleri_ **_Naegleria fowleri_** is the causative agent of **Primary Amebic Meningoencephalitis (PAM)**, a rapidly progressive and highly fatal infection. Transmission occurs when **contaminated water** containing the ameba enters through the nose, typically during swimming or diving in warm freshwater. The ameba then travels along the **olfactory nerve** to the brain, causing rapid tissue destruction. _Naegleria fowleri_ exists in three forms: a **cyst**, an **amoeboid trophozoite** (which is the infective stage), and a **flagellate form**. Diagnosis involves identifying **motile trophozoites** in **CSF** (cerebrospinal fluid). CSF analysis typically reveals high neutrophil counts, elevated protein levels, and low glucose. Treatment primarily involves **Amphotericin B**, administered intravenously or intrathecally. ### B. _Acanthamoeba_ Species **_Acanthamoeba_ species** are responsible for two main diseases: **Granulomatous Amebic Encephalitis (GAE)** and **Acanthamoeba Keratitis**. **GAE** primarily affects **immunocompromised individuals**, where the ameba spreads **hematogenously** to the **CNS** (central nervous system). **Acanthamoeba Keratitis** is a corneal infection often associated with **contact lens wear** and minor eye trauma. The trophozoites of _Acanthamoeba_ are characterized by their distinctive **spine-like pseudopodia (acanthopodia)**. Their cysts are **double-walled and polygonal**. Treatment for GAE typically involves a combination of **Amphotericin B**, **miconazole**, and **sulfadiazine**. **Keratitis** is usually treated with topical agents such as **PHMB** or **chlorhexidine**. ### C. _Balamuthia mandrillaris_ **_Balamuthia mandrillaris_** is another free-living ameba that causes **GAE**, predominantly in *